Embecta Corp. Common Stock (EMBC)
Stock · NASDAQ · Health Care
$6.27as of 10/16/2026
Price chart
Active signals
EMBC Signal Track Record
How signals performed across all stocks →What EMBC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -5.4% | 33% | September 18, 2026 |
| Bollinger Band Breakdown | 21 | -5.3% | 24% | May 5, 2026 |
| Bollinger Band Breakout | 19 | -3.6% | 47% | September 4, 2026 |
| 200-Day Moving Average TouchActive now | 16 | -0.6% | 50% | January 22, 2026 |
| Any 20-session window (baseline) | -3.2% | 42% |
Computed by MarketWall from daily closing prices since January 5, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EMBC
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was for…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 1,850
- Website
- www.embecta.com/
Fundamentals
- 1-day range
- $6.19$6.58
- Market cap
- $207.65M
- P/E (trailing)
- 4.00
- P/E (forward)
- 3.66
- EPS (trailing)
- $1.48
- Dividend yield
- 3.43%
- Beta
- 0.87
- Avg. volume
- 1.33M
- Ex-dividend date
- August 27, 2026
- Dividend pay date
- September 15, 2026
How Embecta Corp. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Dec 11, 2024 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Embecta Corp. Common Stock Competitors
Chosen by industry and closest market cap.
- EMBCEmbecta Corp. Common Stock$6.27▼ 2.79%Market cap $207.65MP/E 4.00$2.77$14.91
- PDEXPro-Dex Inc. Common Stock$58.26▼ 2.93%Market cap $209.06MP/E 14.11$23.47$77
- SENSSenseonics Holdings Inc. Common Stock$7.77▼ 5.59%Market cap $215.29MP/E —$4.79$10.64
- LUCDLucid Diagnostics Inc. Common Stock$0.478▼ 8.08%Market cap $193.54MP/E —$0.5$1.63
- INFUInfuSystems Holdings Inc. Common Stock$13.4▼ 3.74%Market cap $236.42MP/E 31.71$7.29$13.85
- APYXApyx Medical Corporation Common Stock$2.55▼ 0.39%Market cap $174.35MP/E —$2.32$5.08
- KRMDKORU Medical Systems Inc. Common Stock (DE)$3▼ 0.99%Market cap $163.52MP/E —$2.86$6.61
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EMBC Embecta Corp. Common Stock | $207.65M | 4.00 | $6.27 | ▼ 2.79% | $2.77$14.91 |
| PDEX Pro-Dex Inc. Common Stock | $209.06M | 14.11 | $58.26 | ▼ 2.93% | $23.47$77 |
| SENS Senseonics Holdings Inc. Common Stock | $215.29M | — | $7.77 | ▼ 5.59% | $4.79$10.64 |
| LUCD Lucid Diagnostics Inc. Common Stock | $193.54M | — | $0.478 | ▼ 8.08% | $0.5$1.63 |
| INFU InfuSystems Holdings Inc. Common Stock | $236.42M | 31.71 | $13.4 | ▼ 3.74% | $7.29$13.85 |
| APYX Apyx Medical Corporation Common Stock | $174.35M | — | $2.55 | ▼ 0.39% | $2.32$5.08 |
| KRMD KORU Medical Systems Inc. Common Stock (DE) | $163.52M | — | $3 | ▼ 0.99% | $2.86$6.61 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Milton Mayo Morris · September 4, 2026 · Sale6.3K @ $5.88
- Devdatt Kurdikar · August 12, 2026 · Buy30.0K @ $4.7
- Jacob Elguicze · August 12, 2026 · Buy20.0K @ $4.67
- Jeffrey Z. Mann · August 12, 2026 · Buy20.0K @ $4.99
- Robert J. Hombach · August 12, 2026 · Buy45.0K @ $4.97
- Jean Casner · August 9, 2026 · Tax Withholding1.5K @ $4.42
- Anthony M. Roth · June 1, 2026 · Grant30.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 58.20M
- Total value held
- $489.15M
- Institutional holders
- 330
- Unknown9.17M
- Unknown3.67M
- Unknown3.45M
- Unknown3.44M
- Unknown2.56M
- Unknown2.55M
- Unknown2.53M
- Unknown2.36M
- Unknown1.85M
- Unknown1.59M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Concentra Group Hits 52-Week High Amid Medical Services Trends
Concentra Group Holdings, the parent company of Embecta, recently reached a 52-week high, prompting questions about the sustainability of this price movement. This development is relevant to Embecta shareholders as it reflects broader sentiment in the medical services sector. Embecta itself trades with a low trailing P/E of 3.7 and offers a dividend yield of 3.43%, while its stock remains significantly below its 52-week high of $14.91.
Concentra Group Hits 52-Week High Amid Medical Services Trends. Concentra Group Holdings, the parent company of Embecta, recently reached a 52-week high, prompting questions about the sustainability of this price movement. This development is relevant to Embecta shareholders as it reflects broader sentiment in the medical services sector. Embecta itself trades with a low trailing P/E of 3.7 and offers a dividend yield of 3.43%, while its stock remains significantly below its 52-week high of $14.91.